DEA Releases Telehealth Rules
On January 15, 2025, the Drug Enforcement Administration (DEA) released a proposed rule establishing a framework for practitioners to prescribe Schedule II-V controlled substances via telemedicine without a prior in-person medical evaluation entitled, Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation.